Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06643897
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination CabotegravirRilpivirina
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination CabotegravirRilpivirina as an Optional Therapy in People Living With HIV From Spain
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will identify the barriers and facilitators of implementation of the out-of-hospital administration of CABRPV LA from the point of view of staff participating in the study
Detailed Description:
This substudy will use a qualitative descriptive approach based on Consolidated Framework for Implementation Research CFIR Data will be collected using semi-structured interviews among HOLA staff participants until achieving data saturation Data will be analyzed using Braun amp Clarke39s thematic analysis method
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None